Genetics of hypophosphatasia

Clinical Reviews in Bone and Mineral Metabolism

Volumn 11, Issue 2, 2013, Pages 71-77

  Mornet, Etienne ^a,b  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

ALPL mutations; Dominant inheritance; Genetics; Genotype phenotype correlation; Hypophosphatasia

Indexed keywords

ALKALINE PHOSPHATASE;

ARTICLE; BONE; CLINICAL FEATURE; CONSANGUINITY; DISEASE SEVERITY; ENZYME ACTIVITY; EUROPE; EXON; GENE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPOPHOSPHATASIA; IN VITRO STUDY; INCIDENCE; INHERITANCE; KIDNEY; LIVER; MISSENSE MUTATION;

EID: 84884352917     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-013-9140-7     Document Type: Article

References (59)

1. Brun-Heath I, Ermonval M, Chabrol E, Xiao J, Palkovits M, Lyck R, Miller F, Couraud PO, Mornet E, Fonta C. Differential expression of the bone and the liver tissue non-specific alkaline phosphatase isoforms in brain tissues. Cell Tissue Res. 2011;343:521-36.
2. Cai G, Michigami T, Yamamoto T, Yasui N, Satomura K, Yamagata M, Shima M, Nakajima S, Mushiake S, Okada S, Ozono K. Analysis of localization of mutated tissue-nonspecific alkaline phosphatase proteins associated with neonatal hypophosphatasia using green fluorescent protein chimeras. J Clin Endocrinol Metab. 1998;83:3936-42. (Pubitemid 28513576)
3. Eastman JR, Bixler D. Clinical, laboratory, and genetic investigations of hypophosphatasia: support for autosomal dominant inheritance with homozygous lethality. J Craniofac Genet Dev Biol. 1983;3:213-34. (Pubitemid 14242045)
4. Eberic FHS, Pralle H, Kabish A. Adult hypophosphatasia without apparent skeletal disease: "odontohypophosphatasia" in four heterozygote members of a family. Klin Wochenschr. 1984;62:371.
5. Fauvert D, Brun-Heath I, Lia-Baldini AS, Bellazi L, Taillandier A, Serre JL, de Mazancourt P, Mornet E. Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles. BMC Med Genet. 2009;10:51.
6. Fraser D. Hypophosphatasia. Am J Med. 1957;22:730-46.
7. Fukushi M, Amizuka N, Hoshi K, Ozawa H, Kumagai H, Omura S, Misumi Y, Ikehara Y, Oda K. Intracellular retention and degradation of tissue-nonspecific alkaline phosphatase with a Gly317->Asp substitution associated with lethal hypophosphatasia. Biochem Biophys Res Commun. 1998;246:613-8. (Pubitemid 28420906)
8. Fukushi-Irie M, Ito M, Amaya Y, Amizuka N, Ozawa H, Omura S, Ikehara Y, Oda K. Possible interference between tissue-non-specific alkaline phosphatase with an Arg54->Cys substitution and acounterpart with an Asp277->Ala substitution found in a compound heterozygote associated with severe hypophosphatasia. Biochem J. 2000;348(Pt 3):633-42. (Pubitemid 30410254)
9. Greenberg CR, Taylor CL, Haworth JC, Seargeant LE, Philipps S, Triggs-Raine B, Chodirker BN. A homoallelic Gly317->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics. 1993;17:215-7. (Pubitemid 23205080)
10. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL. Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp 1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol. 2004;164:1199-209. (Pubitemid 38387787)
11. Henthorn PS, Raducha M, Fedde KN, Lafferty MA, Whyte MP. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci USA. 1992;89:9924-8.
12. Herasse M, Spentchian M, Taillandier A, Mornet E. Evidence of a founder effect for the tissue-nonspecific alkaline phosphatase (TNSALP) gene E174K mutation in hypophosphatasia patients. Eur J Hum Genet. 2002;10:666-8. (Pubitemid 35277300)
13. Herasse M, Spentchian M, Taillandier A, Keppler-Noreuil K, Fliorito AN, Bergoffen J, Wallerstein R, Muti C, Simon-Bouy B, Mornet E. Molecular study of three cases of odontohypophosphatasia resulting from heterozygosity for mutations in the tissue non-specific alkaline phosphatase gene. J Med Genet. 2003;40:605-9. (Pubitemid 37046915)
14. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci USA. 2002;99:9445-9. (Pubitemid 34764633)
15. Hu JC, Plaetke R, Mornet E, Zhang C, Sun X, Thomas HF, Simmer JP. Characterization of a family with dominant hypophosphatasia. Eur J Oral Sci. 2000;108:189-94.
16. Ishida Y, Komaru K, Ito M, Amaya Y, Kohno S, Oda K. Tissue-nonspecific alkaline phosphatase with an Asp(289)->Val mutation fails to reach the cell surface and undergoes proteasome-mediated degradation. J Biochem (Tokyo). 2003;134:63-70. (Pubitemid 37071181)
17. Ishida Y, Komaru K, Oda K. Molecular characterization of tissue-nonspecific alkaline phosphatase with an Ala to Thr substitution at position 116 associated with dominantly inherited hypophosphatasia. Biochim Biophys Acta. 2011;1812:326-32.
18. Ito M, Amizuka N, Ozawa H, Oda K. Retention at the cis-Golgi and delayed degradation of tissue-non-specific alkaline phosphatase with an Asn153->Asp substitution, a cause of perinatal hypophosphatasia. Biochem J. 2002;361:473-80. (Pubitemid 34177816)
19. Komaru K, Ishida Y, Amaya Y, Goseki-Sone M, Orimo H, Oda K. Novel aggregate formation of a frame-shift mutant protein of tissue-nonspecific alkaline phosphatase is ascribed to three cysteine residues in the C-terminal extension. Retarded secretion and proteasomal degradation. FEBS J. 2005;272:1704-17. (Pubitemid 40516220)
20. Lia-Baldini AS, Muller F, Taillandier A, Gibrat JF, Mouchard M, Robin B, Simon-Bouy B, Serre JL, Aylsworth AS, Bieth E, Delanote S, Freisinger P, Hu JC, Krohn HP, Nunes ME, Mornet E. A molecular approach to dominance in hypophosphatasia. Hum Genet. 2001;109:99-108. (Pubitemid 32743199)
21. Lia-Baldini AS, Brun-Heath I, Carrion C, Simon-Bouy B, Serre JL, Nunes ME, Mornet E. A new mechanism of dominance in hypophosphatasia: the mutated protein can disturb the cell localization of the wild-type protein. Hum Genet. 2008;123:429-32.
22. Matsuura S, Kishi F, Kajii T. Characterization of a 5′-flanking region of the human liver/bone/kidney alkaline phosphatase gene: two kinds of mRNA from a single gene. Biochem Biophys Res Commun. 1990;168:993-1000. (Pubitemid 20175978)
23. Michigami T, Uchihashi T, Suzuki A, Tachikawa K, Nakajima S, Ozono K. Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia. Eur J Pediatr. 2005;164:277-82. (Pubitemid 40603309)
24. Millan J. Mammalian alkaline phosphatases: from biology to applications in medicine and biotechnology. Weinheim: Wiley-VCH Verlag GmbH; 2006.
25. Moore CA, Curry CJ, Henthorn PS, Smith JA, Smith JC, O'Lague P, Coburn SP, Weaver DD, Whyte MP. Mild autosomal dominant hypophosphatasia: in utero presentation in two families. Am J Med Genet. 1999;86:410-5. (Pubitemid 29503191)
26. Mornet E. Hypophosphatasia. Best Pract Res Clin Rheumatol. 2008;22:113-27. (Pubitemid 351336923)
27. Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH. Structural evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone mineralization. J Biol Chem. 2001;276:31171-8.
28. Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011;75:439-45.
29. Muller HL, Yamazaki M, Michigami T, Kageyama T, Schonau E, Schneider P, Ozono K. Asp361Val Mutant of alkaline phosphatase found in patients with dominantly inherited hypophosphatasia inhibits the activity of the wild-type enzyme. J Clin Endocrinol Metab. 2000;85:743-7. (Pubitemid 32273663)
30. Mumm S, Wenkert D, Zhang X, Geimer M, Zerega J, Whyte MP. Hypophosphatasia: the c.1133A>T, D378V transversion is the most common American TNSALP mutation. Paper presented at Fifth International Alkaline Phosphatase Symposium: "Understanding alkaline phosphatase function - Pathophysiology and treatment of Hypophosphatasia and other AP-related diseases" Huningue, France; 2007.
31. Nasu M, Ito M, Ishida Y, Numa N, Komaru K, Nomura S, Oda K. Aberrant interchain disulfide bridge of tissue-nonspecific alkaline phosphatase with an Arg433->Cys substitution associated with severe hypophosphatasia. FEBS J. 2006;273:5612-24. (Pubitemid 44915886)
32. Numa N, Ishida Y, Nasu M, Sohda M, Misumi Y, Noda T, Oda K. Molecular basis of perinatal hypophosphatasia with tissue-nonspecific alkaline phosphatase bearing a conservative replacement of valine by alanine at position 406. Structural importance of the crown domain. FEBS J. 2008;275:2727-37. (Pubitemid 351678661)
33. Orimo H. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nihon Med Sch. 2010;77:4-12.
34. Orimo H, Goseki-Sone M, Inoue M, Tsubakio Y, Sakiyama T, Shimada T. Importance of deletion of T at nucleotide 1559 in the tissue-nonspecific alkaline phosphatase gene in Japanese patients with hypophosphatasia. J Bone Miner Metab. 2002;20:28-33. (Pubitemid 34101092)
35. Pauli RM, Modaff P, Sipes SL, Whyte MP. Mild hypophosphatasia mimicking severe osteogenesis imperfecta in utero: bent but not broken. Am J Med Genet. 1999;86:434-8. (Pubitemid 29503196)
36. Petkovic Ramadza D, Stipoljev F, Sarnavka V, Begovic D, Potocki K, Fumic K, Mornet E, Baric I. Hypophosphatasia: phenotypic variability and possible Croatian origin of the c.1402g>A mutation of TNSALP gene. Coll Antropol. 2009;33:1255-8.
37. Rodrigues TL, Foster BL, Silverio KG, Martins L, Casati MZ, Sallum EA, Somerman MJ, Nociti FH. Correction of hypophosphatasia (Hpp) associated mineralization deficiencies in vitro by phosphate/pyrophosphate modulation in periodontal ligament cells. J Periodontol. 2012;83:653-63.
38. Satou Y, Al-Shawafi HA, Sultana S, Makita S, Sohda M, Oda K. Disulfide bonds are critical for tissue-nonspecific alkaline phosphatase function revealed by analysis of mutant proteins bearing a C(201)-Y or C(489)-S substitution associated with severe hypophosphatasia. Biochim Biophys Acta. 2012;1822:581-8.
39. Shibata H, Fukushi M, Igarashi A, Misumi Y, Ikehara Y, Ohashi Y, Oda K. Defective intracellular transport of tissue-nonspecific alkaline phosphatase with an Ala162->Thr mutation associated with lethal hypophosphatasia. J Biochem (Tokyo). 1998;123:968-77. (Pubitemid 28226997)
40. Spentchian M, Brun-Heath I, Taillandier A, Fauvert D, Serre JL, Simon-Bouy B, Carvalho F, Grochova I, Mehta SG, Muller G, Oberstein SL, Ogur G, Sharif S, Mornet E. Characterization of missense mutations and large deletions in the ALPL gene by sequencing and quantitative multiplex PCR of short fragments. Genet Test. 2006;10:252-7. (Pubitemid 46193275)
41. Studer M, Terao M, Gianni M, Garattini E. Characterization of a second promoter for the mouse liver/bone/kidney-type alkaline phosphatase gene: cell and tissue specific expression. Biochem Biophys Res Commun. 1991;179:1352-60.
42. Taillandier A, Sallinen SL, Brun-Heath I, De Mazancourt P, Serre JL, Mornet E. Childhood hypophosphatasia due to a de novo missense mutation in the tissue-nonspecific alkaline phosphatase gene. J Clin Endocrinol Metab. 2005;90:2436-9. (Pubitemid 40586296)
43. Takinami H, Goseki-Sone M, Watanabe H, Orimo H, Hamatani R, Fukushi-Irie M, Ishikawa I. The mutant (F310L and V365I) tissue-nonspecific alkaline phosphatase gene from hypophosphatasia. J Med Dent Sci. 2004;51:67-74. (Pubitemid 41114825)
44. Terao M, Studer M, Gianni M, Garattini E. Isolation and characterization of the mouse liver/bone/kidney-type alkaline phosphatase gene. Biochem J. 1990;268:641-8. (Pubitemid 20196947)
45. Toh Y, Yamamoto M, Endo H, Misumi Y, Ikehara Y. Isolation and characterization of a rat liver alkaline phosphatase gene. A single gene with two promoters. Eur J Biochem. 1989;182:231-7. (Pubitemid 19165408)
46. Watanabe A, Satoh S, Fujita A, Naing BT, Orimo H, Shimada T. Perinatal (lethal) type of hypophosphatasia resulting from paternal isodisomy of chromosome 1. Paper presented at 6th alkaline phosphatase and hypophosphatasia symposium, May 16-19. Huningue, France. 2012.
47. Watanabe H, Takinami H, Goseki-Sone M, Orimo H, Hamatani R, Ishikawa I. Characterization of the mutant (A115V) tissue-nonspecific alkaline phosphatase gene from adult-type hypophosphatasia. Biochem Biophys Res Commun. 2005;327:124-9. (Pubitemid 40051361)
48. Watanabe A, Karasugi T, Sawai H, Naing BT, Ikegawa S, Orimo H, Shimada T. Prevalence of c.1559delT in ALPL, a common mutation resulting in the perinatal (lethal) form of hypophosphatasia in Japanese and effects of the mutation on heterozygous carriers. J Hum Genet. 2011;56:166-8.
49. Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA, Harris H. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci USA. 1988;85:7666-9.
50. Weiss MJ, Ray K, Henthorn PS, Lamb B, Kadesch T, Harris H. Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem. 1988;263:12002-10.
51. Wenkert D, McAlister WH, Coburn S, Ryan L, Hersh JH, Zerega J, Mumm S, MP W. Non-lethal hypophosphatasia interpreted as severe skeletal dysplasia in utero. Paper presented at fifth international alkaline phosphatase symposium: "Understanding alkaline phosphatase function - Pathophysiology and treatment of Hypophosphatasia and other AP-related diseases" Huningue, France. 2007.
52. Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL, Hersh JH, Mumm S, Whyte MP. Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res. 2011;26:2389-98.
53. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev. 1994;15:439-61. (Pubitemid 24271239)
54. Whyte MP, Teitelbaum SL, Murphy WA, Bergfeld MA, Avioli LV. Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore). 1979;58:329-47. (Pubitemid 10234877)
55. Whyte MP, Vrabel LA, Schwartz TD. Adult hypophosphatasia: generalized deficiency of alkaline phosphatase activity demonstrated with cultured skin fibroblasts. Trans Assoc Am Phys. 1982;95:253-63.
56. Whyte MP, Essmyer K, Geimer M, Mumm S. Homozygosity for TNSALP mutation 1348c>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr. 2006;148:753-8. (Pubitemid 43870081)
57. Yadav MC, Simao AM, Narisawa S, Huesa C, McKee MD, Farquharson C, Millan JL. Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res. 2011;26:286-97.
58. Zhang H, Ke YH, Wang C, Yue H, Hu WW, Gu JM, Zhang ZL. Identification of the mutations in the tissue-nonspecific alkaline phosphatase gene in two Chinese families with hypophosphatasia. Arch Med Res. 2012;43:21-30.
59. Zurutuza L, Muller F, Gibrat JF, Taillandier A, Simon-Bouy B, Serre JL, Mornet E. Correlations of genotype and phenotype in hypophosphatasia. Hum Mol Genet. 1999;8:1039-46. (Pubitemid 29250891)